PhaseRx, Inc.: Chapter 11 case summary
ElevenFlo ·
PhaseRx’s Chapter 11 case, filed on December 11, 2017, was dismissed on March 23, 2018 under the dismissal order Dkt. 209. The court had previously authorized a sale of substantially all of the company’s assets; no later case milestone is identified.
PhaseRx’s Chapter 11 case, filed on December 11, 2017, was dismissed on March 23, 2018 under the dismissal order Dkt. 209. Before dismissal, the court entered a sale order Dkt. 147 on February 1, 2018 authorizing the sale of substantially all of the debtor’s assets. The order establishes authorization, not completion of the sale.
PhaseRx, a biopharmaceutical company developing mRNA therapies for inherited liver enzyme deficiencies, entered Chapter 11 after losses and a declining cash position. Its first-day declaration Dkt. 11 reported $1,760,925 in cash and equivalents and at least $5,156,007.53 owed to secured lender Hercules Capital, plus accrued interest, fees and other amounts. Hercules held liens on substantially all of the company’s assets. The board had engaged an investment banker to explore asset sales and chose a Chapter 11 sale process.
The court authorized use of cash collateral on a final basis in the January 3 order Dkt. 82 and extended and modified that authorization in the February 1 supplemental order Dkt. 148.
Sources
- Dkt. 11First Day DeclarationFiled Dec 11, 2017Dec 11, 2017
- Dkt. 82Order (FINAL) (I) Authorizing Use of Cash Collateral, (II) Granting Adequate Protection to Secured Parties, AND (III) Granting Related Relief (related document(s)10, 26) Order Signed on 1/3/2018. (Attachments: # 1 Exhibit 1) (DMC) (Entered: 01/03/2018)Filed Jan 3, 2018Jan 3, 2018
- Dkt. 147Order (A) Approving the Asset Purchase Agreement Between the Debtor and the Purchaser, (B) Authorizing the Sale to the Purchaser of Substantially All of the Debtor's Assets Free and Clear of All Liens, Claims, Encumbrances, and Interests, Except for Permitted Encumbrances and Assumed Liabilities, (C) Authorizing the Assumption and Assignment of Contracts, and (D) Granting Related Relief (related document(s)12, 60, 127, 144). Signed on 2/1/2018. (Attachments: # 1 Exhibit 1) (SJS) (Entered: 02/01/2018)Filed Feb 1, 2018Feb 1, 2018
- Dkt. 148Order (SUPPLEMENTAL) Extending and Modifying the Final Order (I) Authorizing Use of Cash Collateral, (II) Granting Adequate Protection to Secured Parties, and (III) Granting Related Relief (related document(s)10, 26, 82, 146). Signed on 2/1/2018. (Attachments: # 1 Exhibit 1) (SJS) (Entered: 02/01/2018)Filed Feb 1, 2018Feb 1, 2018
- Dkt. 209Order Granting Motion to Dismiss Case (Related Doc # 190) Order Signed on 3/23/2018. (DMC) (Entered: 03/23/2018)Filed Mar 23, 2018Mar 23, 2018